Ton Adang

Ton Adang worked at several biotech companies and at Merck/MSD, Schering-Plough and Organon in research and development positions with increasing responsibilities. He held leadership positions in the Lead Discovery Unit and in project management, developing a product through FDA approval and targeting new indications like breast cancer, osteoporosis as well as working with human vaccines, biosimilars and in immune oncology. He received his PhD from the University of Leiden at the Divisions of Bio-Pharmaceutical Sciences and Bio-Organic Chemistry.